JUN 17, 2021 11:00 AM BST

Practical advice for working with regulators

Speaker

Abstract
In vitro diagnostic (IVD) products enable the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease. Regulatory agencies have a critical role to play in protecting public health and with IVD products primarily used in the collection, preparation, and examination of samples from the human body they need to ensure they are safe, accurately labelled and effective.  Given the scale of the responsibility, a complex and lengthy approval process can sometimes prevail. 
With so many elements involved in the development of diagnostic kits and particularly novel tests, developers, scientists, and researchers, often find the regulatory approval process cumbersome and a potential barrier to commercialization. 
Join Dr. Shamiram Feinglass, CMO & VP Global Medical Affairs and Policy at Danaher, for top tips on how to work with the regulators effectively, the key steps in the process and what you can do to ensure a successful regulatory outcome. 
Learning objectives 
  • Understand the role of government agencies and regulatory bodies in the development of diagnostic tests
  • Review the impact of unexpected global health trends on the approval of novel tests  
  • Consider the timelines, steps, and challenges in the regulatory approval process 
  • Learn how to work with regulators for successful filing.  

Show Resources
You May Also Like
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
C.E. CREDITS
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with multiple motor and non-motor symptoms. PD is characterized by the presence on proteinaceous neuronal...
Loading Comments...
Show Resources